Fabian Benencia

Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.

Effect of undernourishment on Herpes Simplex Virus Type 1 ocular infection in the Wistar rat model.

Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm.

Nitric oxide and HSV vaginal infection in BALB/c mice.

Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells.

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.

Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route.

Early inhibition of nitric oxide production increases HSV-1 intranasal infection.

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.

Vascular leukocytes contribute to tumor vascularization.

Expression of IL-15, IL-18 and NOS-II in contralateral eyes of BALB/c mice during the development of HSV-induced keratitis.

HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer.

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma.

Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment.

Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity.

Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer.

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells.

Wnt5a is expressed in murine and human atherosclerotic lesions.

Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation.

Biological therapy with oncolytic herpesvirus.

Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.

Modulation of the antitumor immune response by complement.

In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes.

Aminoguanidine administered during the induction of oral tolerance alters the systemic response of the tolerised rats.

Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18.

Whole tumor antigen vaccines.

Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.

The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.